|
|
|
Sponsors
|
Université de Strasbourg |
| Sponsorship by the University of Strasbourg is from IDEX funds (Investissements d'Avenir) The University of Strasbourg is the second largest university in France, with about 43,000 students and over 4,000 researchers. It is 89th in the Shanghai ranking, and the first non parisian french university in this ranking. Three Nobel prizes are active in the University: Prof Jean-Marie Lehn (Chemistry) and Jules Hoffmann (Physiology and Medicine) who spent their almost entire carrier in Strasbourg University, and Prof Martin Karplus (Chemistry). Among other alumni (students or professors), one can cite Wolfgang von Goethe, Georg Büchner, Louis Pasteur, F. von Recklinghausen (neurofibromatosis, hemochromatosis), Pierre Chambon, Arsene Wenger (of Arsenal fame), Jean-Claude Juncker (current president of the European Commission) etc... | |
|
|
| Region Alsace The Region Alsace counts 1.6 million inhabitants. Its capital is Strasbourg | |
|
TNR Diagnostics |
| TNR Diagnostics is a life sciences start-up which is focused on providing accurate and user-friendly in vitro tests for the rapid screening and characterization of genetic repeat disorders. The tests are based on innovative diagnostic solutions developed at the National University of Singapore (NUS). As an incubatee of The Biofactory, TNR Diagnostics was able to accelerate the development and launch of these novel in-vitro diagnostic kits. TNR Diagnostics is currently developing FastFraX IVD kits for first-line screening and diagnosis of Fragile X Syndrome. The company is also exploring solutions for the screening and diagnosis of other genetic repeat disorders such as Huntington’s Disease and Myotonic Dystrophy Type 1. | |
|
Agilent Technologies |
| Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions. | |
|
Alcobra-Pharma |
| We are a publicly traded, emerging pharmaceutical company (NASDAQ: ADHD) primarily focused on the development and commercialization of our proprietary drug, METADOXINE EXTENDED RELEASE (MDX), to treat cognitive disorders including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome (FXS). | |
|
Illumina |
|
Fondation Jérome Lejeune |
| In 1959, Professor Jérôme Lejeune, doctor and researcher, discovered the cause of Down syndrome (trisomy 21). Subsequently, the Jérôme Lejeune Foundation, which was given public interest status in 1996, has been working for individuals affected by genetic intelligence disorders (Down syndrome, Williams-Beuren syndrome, fragile X syndrome, “cri du chat” syndrome, other trisomies, monosomies and unexplained intellectual disability…). | |
|
Roche |
| Roche France est une entreprise de santé humaine, engagée dans la lutte contre le cancer, dans l'innovation médicale et les biotechnologies. | |
|
New England BioLabs |
| Founded in the mid-1970s as a collective of scientists committed to developing innovative products for the life sciences industry, New England Biolabs is now a recognized world leader in the discovery, development and commercialization of recombinant and native enzymes for genomic research. | |
|
Dutscher |
| Dominique Dutscher vous propose un grand nombre de consommables et matériels pour laboratoires en rapport avec les disciplines de la génétique | |
|
Asuragen |
| Asuragen is a molecular diagnostics company driving better patient management in oncology and genetic disorders through best-in-class clinical testing solutions. The company discovers, develops and commercializes diagnostic products for use in clinical laboratories and to serve our Bio/Pharma partners’ diagnostic needs. Asuragen’s development of innovative diagnostic products will help transform medicine by improving clinical outcomes and health economics. |
| Online user: 1 |
|
